Teristrong 600 mcg Pen Injection 2.4 ml

Teristrong 600 mcg Pen Injection 2.4 ml belongs to the class of medication called 'anabolic (promoting bone formation) agent' indicated for prevention and treatment of osteoporosis in adults and helps to strengthen the bone. This medicine also helps to reduce the risk of spine and hip fractures. Osteoporosis is a medical condition in which bone becomes thin or weak. The chance of developing osteoporosis increases with age, after menopause or by taking corticosteroid medications (such as prednisone) for a long period. If proper treatment is not provided then it can even result in broken bones.

Teristrong 600 mcg Pen Injection 2.4 ml contains Teriparatide a synthetic form of the human parathyroid hormone, which helps to regulate calcium metabolism. Teristrong 600 mcg Pen Injection 2.4 ml works by causing the body to build new bone by increasing bone strength and bone mass density (BMD) (thickness) and reduce the risk of fractures by stimulating bone formation. It also increases the thickness of bone and rebuilds bones which reduces the risk of spine and hip fractures.

Teristrong 600 mcg Pen Injection 2.4 ml will be administered by a healthcare professional; do not self-administer. In some cases, Teristrong 600 mcg Pen Injection 2.4 ml can cause side effects like nausea, vomiting,  joint pain, leg cramps, swelling/redness at the injection site, upset stomach, diarrhea, constipation, runny nose, cough, and throat irritation. Most of these side effects of Teristrong 600 mcg Pen Injection 2.4 ml do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.

To treat your condition effectually, continue taking Teristrong 600 mcg Pen Injection 2.4 ml for as long as your doctor has prescribed. Consult your doctor before taking Teristrong 600 mcg Pen Injection 2.4 ml if you are pregnant or breastfeeding; your doctor will prescribe you Teristrong 600 mcg Pen Injection 2.4 ml only if the benefits outweigh the risks. Teristrong 600 mcg Pen Injection 2.4 ml is not recommended for children below 18 years of age.  Tell your doctor that you are taking Teristrong 600 mcg Pen Injection 2.4 ml before you have any lab test as this medicine could interfere with the results. Teristrong 600 mcg Pen Injection 2.4 ml may cause dizziness, lightheadedness, and fainting when you get up too quickly from a lying position. To avoid this problem, get out of bed slowly, resting your feet on the floor for a few minutes before standing up. Inform your doctor about your health condition and medications before taking Teristrong 600 mcg Pen Injection 2.4 ml to rule out any side effects. Teristrong 600 mcg Pen Injection 2.4 ml is a cold chain medicine, and so it has to be stored in the refrigerator between 2-8 degrees Celsius else its efficiency might be lost. Do not store in the freezer or the fridge.

Teristrong 600 mcg Pen Injection 2.4 ml is used in the treatment of Osteoporosis, Postmenopausal osteoporosis. The detailed uses of Teristrong 600 mcg Pen Injection 2.4 ml are as follows:

• Postmenopausal Osteoporosis: Teristrong 600 mcg Pen Injection 2.4 ml is used for women at high risk of fractures or intolerant to other treatments.
• Primary or Hypogonadal Osteoporosis: Teristrong 600 mcg Pen Injection 2.4 ml helps to increase bone mass in men with high fracture risk.
• Glucocorticoid-Induced Osteoporosis: Teristrong 600 mcg Pen Injection 2.4 ml treats bone loss caused by long-term steroid use.

• Use Teristrong 600 mcg Pen Injection 2.4 ml as directed by your doctor or as per the labelled instructions.
• It is recommended to administer Teristrong 600 mcg Pen Injection 2.4 ml once daily at the same time each day or as advised by your doctor.
• Teristrong 600 mcg Pen Injection 2.4 ml should be administered subcutaneously (under the skin) into the abdomen or thigh.
• Change the injection site each time to prevent the formation of hard lumps.

Teristrong 600 mcg Pen Injection 2.4 ml is a synthetic form of a natural human hormone called parathyroid hormone (PTH) that is prescribed to prevent and treat osteoporosis in persons with weak bones. It prevents the loss of bones that happens after menopause and helps to rebuild bones. Teristrong 600 mcg Pen Injection 2.4 ml contains Teriparatide which works by causing the body to build new bone and by increasing bone strength and bone mass density (BMD) (thickness) and reduce the risk of fractures by stimulating bone formation. It also increases the thickness of bone and rebuilds bones which reduces the risk of spine and hip fractures. Teristrong 600 mcg Pen Injection 2.4 ml is also indicated for the treatment of increasing bone mass in people with osteoporosis, glucocorticoid-induced osteoporosis.

Teristrong 600 mcg Pen Injection 2.4 ml is not recommended if you have hypercalcemia (high calcium levels) or an overactive parathyroid gland, metastatic calcification (extra deposits of calcium in the body) and malabsorption syndrome (difficulty absorbing nutrition from food), kidney stones, kidney problems (moderate renal impairment), Paget’s disease of bone (abnormal bone changes), history of skeletal malignancies. It is important that your doctor check your progress regularly to make sure that Teristrong 600 mcg Pen Injection 2.4 ml is working properly. Blood and urine tests may be needed to check for unwanted effects. Teristrong 600 mcg Pen Injection 2.4 ml can increase the amount of calcium in your blood or urine. Talk to your doctor before or while using Teristrong 600 mcg Pen Injection 2.4 ml if you have continuing nausea, vomiting, constipation, low energy or muscle weakness. These may be signs there is too much calcium in your blood. Consult your doctor before taking Teristrong 600 mcg Pen Injection 2.4 ml if you are pregnant or breastfeeding; your doctor will prescribe you Teristrong 600 mcg Pen Injection 2.4 ml only if the benefits outweigh the risks. Teristrong 600 mcg Pen Injection 2.4 ml should not be given to children as safety and efficacy have not been established. Do not take Teristrong 600 mcg Pen Injection 2.4 ml for longer durations unless prescribed by your doctor. If your condition does not improve even after taking the Teristrong 600 mcg Pen Injection 2.4 ml full course, please consult your doctor.  Teristrong 600 mcg Pen Injection 2.4 ml may increase the risk of having cancer while taking longer durations. Talk to your doctor if you have concerns about this risk. Avoid consuming alcohol along with Teristrong 600 mcg Pen Injection 2.4 ml as it could lead to increased drowsiness. Inform your doctor about your health condition and medications before taking Teristrong 600 mcg Pen Injection 2.4 ml to rule out any side effects.